Track Shalby Ltd.'s current share price, historical price chart, 52-week high/low, and performance across different time periods.
1 Week returns: -1.19 %
Low
159.6
High
168.9
1 Month returns: -4.41 %
Low
159.6
High
182.9
1 Year returns: -20.99 %
Low
125.7
High
274.7
3 Year CAGR: -5.99 %
Low
125.7
High
339.5
5 Year CAGR: -3.47 %
Low
94.9
High
339.5
Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
Multi-year trends for Shalby Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.
Shalby Ltd. Shareholding Pattern
Quarterly breakdown of Shalby Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.
Bulk, Block and Insider Trades
Recent bulk deals, block deals, and insider trading activity in Shalby Ltd. shares as reported to NSE and BSE.
Frequently Asked Questions
What is the current share price of Shalby Ltd.?
The current share price of Shalby Ltd. is ₹ 163.98 as of 27 Jul 2026.
What is the market capitalisation of Shalby Ltd.?
The market capitalisation of Shalby Ltd. stands at ₹ 1,763.47 Cr.
What is the PE ratio of Shalby Ltd.?
The Price-to-Earnings (PE) ratio of Shalby Ltd. is 47.17 as of the latest trailing twelve months data.
What is the ROE and ROCE of Shalby Ltd.?
Shalby Ltd. has a Return on Equity (ROE) of 3.73% and a Return on Capital Employed (ROCE) of 4.73% as per the latest financial reports.
What is the 52-week high and low of Shalby Ltd.?
The 52-week high of Shalby Ltd. is - and the 52-week low is -.
What is the dividend yield of Shalby Ltd.?
The dividend yield of Shalby Ltd. is 0.00% based on the current market price.
What is the FII and DII holding in Shalby Ltd.?
Foreign Institutional Investors (FII) hold 4.47%, Domestic Institutional Investors (DII) hold 0.01% and retail/public investors hold 14.57% of Shalby Ltd. shares.
What sector does Shalby Ltd. belong to?
Shalby Ltd. operates in the Healthcare sector.
What is the beta of Shalby Ltd.?
The beta of Shalby Ltd. is 1.35, indicating its price volatility relative to the broader market. Over the past 1 year, Shalby Ltd. has delivered an absolute return of -17.42%.
What is the RSI of Shalby Ltd.?
The 14-day Relative Strength Index (RSI) of Shalby Ltd. is 43.53, placing it in the neutral zone. An RSI above 70 is considered overbought and below 30 is considered oversold.
Net Revenue FY
Profit After Tax FY
ROE FY
EBITDA FY
Mar 2020
Jun 2020
Sep 2020
Dec 2020
Mar 2021
Jun 2021
Sep 2021
Dec 2021
Mar 2022
Jun 2022
Sep 2022
Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Promoter
79.44
79.44
79.45
79.45
79.45
74.07
74.02
74.02
74.02
74.04
74.04
74.12
74.12
74.12
74.12
74.12
74.24
74.25
74.25
74.27
74.27
74.27
74.33
74.33
74.33
74.33
Indian Promoter
79.44
79.44
79.45
79.45
79.45
74.07
74.02
74.02
74.02
74.04
74.04
74.12
74.12
74.12
74.12
74.12
74.24
10.31
74.25
74.27
74.27
74.27
74.33
74.33
74.33
74.33
Foreign Promoter
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
63.94
-
-
-
-
-
-
-
-
Institutions
4.33
1.55
1.00
0.79
0.84
3.68
4.17
3.83
3.95
3.92
4.06
4.03
3.91
4.00
4.11
4.62
4.88
5.41
5.46
4.79
4.72
5.40
4.84
4.67
4.61
4.76
Mutual Funds / UTI
-
-
-
-
-
-
-
-
-
-
0.00
-
-
-
-
-
-
-
-
-
-
-
-
-
-
0.01
FI/Bank/Insurance
0.08
0.39
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Govt
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
FII
3.68
0.52
0.66
0.79
0.84
3.68
4.17
3.83
3.95
3.92
3.78
3.97
3.92
4.00
4.11
4.62
4.88
5.35
5.37
4.65
4.54
5.21
4.63
4.47
4.36
4.47
Other Institutions
0.58
0.64
0.34
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.28
0.06
0.00
0.00
0.00
0.00
0.00
0.06
0.09
0.14
0.18
0.19
0.19
0.19
0.25
0.29
Non-Institution
16.23
19.01
19.56
19.76
19.71
22.25
21.81
22.15
22.03
22.05
21.90
21.85
21.96
21.88
21.77
21.26
20.89
20.35
20.29
20.94
21.02
20.33
20.84
21.01
21.07
20.91
Bodies Corporate
5.39
6.46
5.42
6.01
5.56
8.18
8.21
7.30
7.32
7.46
7.27
7.50
7.76
7.65
7.56
7.75
7.77
7.84
7.68
7.27
7.02
6.35
6.46
6.43
6.49
6.34
Others (incl. Retail)
No. of shareholders
10.84
54,080
12.55
57,223
14.14
54,844
13.75
54,846
14.15
55,778
14.07
52,314
13.60
53,652
14.85
55,357
14.71
55,050
14.59
54,475
14.63
54,340
14.35
52,570
14.20
51,974
14.23
52,367
14.21
49,977
13.51
49,225
13.12
49,599
12.51
49,076
12.61
51,221
13.67
52,052
14.00
52,649
13.98
53,189
14.38
53,505
14.58
52,214
14.58
51,153
14.57
50,502
Holdings and Presence
Indices and prominent investors with a stake in this stock.
SHAH FAMILY TRUST THROUGH DR. VIKRAM I SHAH TRUSTEE
Promoter
September-2025
Market Purchase (Acquisition)
20th Sep 2025
34.73 %
₹ 240.18
60.00 k
₹ 1.44 cr
DR. VIKRAM INDRAJIT SHAH
Promoter & Director
November-2024
Market Purchase (Acquisition)
15th Nov 2024
7.39 %
₹ 218.19
25.00 k
₹ 54.55 lac
DR. VIKRAM INDRAJIT SHAH
Promoter & Director
November-2024
Market Purchase (Acquisition)
15th Nov 2024
7.39 %
₹ 218.19
25.00 k
₹ 54.55 lac
DR. VIKRAM INDRAJIT SHAH
Promoter & Director
June-2024
Market Purchase (Acquisition)
6th Jun 2024
7.38 %
₹ 254.16
10.00 k
₹ 25.42 lac
VIKRAM INDRAJIT SHAH
Promoter & Director
March-2024
Market Purchase (Acquisition)
7th Mar 2024
7.26 %
₹ 244.20
1.25 lac
₹ 3.05 cr
VIKRAM INDRAJIT SHAH
Promoter
December-2022
Market Purchase (Acquisition)
8th Dec 2022
7.24 %
₹ 149.63
30.00 k
₹ 44.89 lac
VIKRAM INDRAJIT SHAH
Promoter
November-2022
Market Purchase (Acquisition)
29th Nov 2022
7.22 %
₹ 151.67
20.00 k
₹ 30.33 lac
VIKRAM INDRAJIT SHAH
Promoter
November-2022
Market Purchase (Acquisition)
17th Nov 2022
7.20 %
₹ 143.51
20.00 k
₹ 28.70 lac
VIKRAM INDRAJIT SHAH
Promoter
November-2022
Market Purchase (Acquisition)
4th Nov 2022
7.18 %
₹ 144.88
20.00 k
₹ 28.98 lac
Neelu Pratik Kedia
Directors Immediate Relative
October-2022
Market Sale (Disposal)
27th Oct 2022
0.00 %
₹ 145.13
530.00
₹ 76.92 k
Stock Analysis
Fundamental analysis overview of Shalby Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.
Views
Red Flags
Positive
Not enough talking points with positive stance
Negative
Expensive and at same valuation levels as industry median P/E
PE TTM of 47.17 indicates that the stock is expensive on a standalone basis. Discount to industry median P/E is modest at -3.38%
What is P/E Ratio?
Median: 48.82
Value 47.17
-42.633079.57
Analysts have been downgrading forward EPS estimates
Analyst EPS estimate (consensus) for forward EPS has decreased by -31.44% in the last 3 months, indicating weak earnings momentum
What is Earnings upgrade (3M)?
Low dividend yield
The company has a low dividend yield of 0.0%
What is Dividend yield?
Neutral
Company's earnings are of moderate quality
Earnings quality score of 34.7 indicates that the company's earnings are of moderate quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion
What is Earnings quality score?
34.7 / 100
No red flags found!
No significant red flags found in the stock.
Company Profile
Overview of Shalby Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.
Shalby Limited is an India-based company, which operates multi-specialty hospital chains. The Company is engaged in the business of setting up and managing hospitals and medical diagnostic services. The Company’s Hospitals divisions include Multispecialty, Shalby Orthopedics Centre of Excellence (SOCE), Shalby Homecare, and Shalby Academy. Its Slaney Healthcare (Surgical & Pharma Products) divisions include Hosply (Hospital Supplies). Its Shalby MedTech divisions include Shalby Advanced Technologies Inc., USA (SAT), and Shalby Global Technologies PTE Ltd, Singapore (SGT). The Company offers a range of specialties, which include Bone and Joint, Cardiac Sciences, Cosmetic and Aesthetic, Dental Cosmetic and Implantology, Dermatology, Emergency Medicine, ENT Surgery, Gastro Sciences, General Medicine, General Surgery, Infertility and IVF, Intensive and Critical Care, Kidney Sciences, Liver Transplantation, Maxillofacial Surgery, Obstetrics and Gynaecology, Onco Sciences, and more.
Shalby Limited is an India-based company, which operates multi-specialty hospital chains. The Company is engaged in the business of setting up and managing hospitals and medical diagnostic services. The Company’s Hospitals divisions include Multispecialty, Shalby Orthopedics Centre of Excellence (SO...